Photo taken from Nizar Jacques Bahlis/Twitter
Mar 15, 2024, 15:46
Nizar Jacques Bahlis: A plea (and not a criticism) to myeloma community to heavily invest in genomic, immunogenomic and biomarkers studies
Nizar Jacques Bahlis, Associate Professor of Medicine at the University of Calgary, posted on X:
“SMM: Taking the narrow over the wide path. This is a plea (and not a criticism) to the myeloma community to heavily invest in genomic, immunogenomic & biomarkers studies to generate better classifiers of risk of progression or redefine SMM (Smoldering multiple myeloma) as MGUS or MM.”
Read Further.
Source: Nizar Jacques Bahlis/ X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 15, 2024, 21:37
Nov 15, 2024, 21:26
Nov 15, 2024, 21:09
Nov 15, 2024, 21:05
Nov 15, 2024, 21:03
Nov 15, 2024, 21:02
Nov 15, 2024, 20:28
Nov 15, 2024, 19:31
Nov 15, 2024, 17:47
Nov 15, 2024, 17:45